See more : Western Acquisition Ventures Corp. (WAVS) Income Statement Analysis – Financial Results
Complete financial analysis of Dong-A Socio Holdings Co., Ltd. (000640.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dong-A Socio Holdings Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- NeoCore Technology Co., Ltd. (4131.TWO) Income Statement Analysis – Financial Results
- Phoenix Pioneer technology Co., Ltd. (6920.TWO) Income Statement Analysis – Financial Results
- Azorim-Investment, Development & Construction Co. Ltd (AZRM.TA) Income Statement Analysis – Financial Results
- Banestes S.A – Banco do Estado do Espírito Santo (BEES3.SA) Income Statement Analysis – Financial Results
- Southwest Airlines Co. (SWN.DE) Income Statement Analysis – Financial Results
Dong-A Socio Holdings Co., Ltd. (000640.KS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.donga.co.kr
About Dong-A Socio Holdings Co., Ltd.
Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally. It offers Bacchus, Benachio, and Tempo; infection management products; imaging equipment, such as FX-V1 and CLS-S7 for surgery and diagnosis; and MEDIFLIX, a medical knowledge-sharing platform. The company provides business management services; CMO services, including pre-clinical study, clinical trial, and commercial production of antibodies and recombinant proteins; maintenance, repair, and operation; quarantine; and military logistics services; and packaging and parcel delivery services. In addition, it offers mineral water under the Gayasan Cheonnyeonsu brand; POCARI SWEAT; Narangd cider; Oronamin C; Oran-C bio-PET; and STP2104, an mRNA based COVID-19 vaccine, which is in phase I clinical trial. Further, the company engages in the construction of industrial facilities, such as bio, pharmaceutical, food, logistics warehouses, education/research facilities, work/sales facilities, and public facilities; provides design, maintenance, and asset development services. Additionally, it provides IT systems development and maintenance. The company was founded in 1932 and is headquartered in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,132.00B | 1,014.86B | 881.94B | 783.32B | 769.69B | 707.17B | 690.26B | 726.17B | 704.73B | 630.63B | 570.87B | 1,106.00B | 1,055.70B | 947.64B | 866.23B | 763.59B | 686.81B |
| Cost of Revenue | 757.13B | 720.48B | 600.46B | 521.33B | 504.73B | 471.81B | 444.50B | 442.85B | 457.32B | 439.09B | 386.83B | 607.81B | 533.19B | 421.72B | 388.50B | 327.90B | 306.83B |
| Gross Profit | 374.87B | 294.39B | 281.48B | 261.98B | 264.95B | 235.36B | 245.77B | 283.31B | 247.41B | 191.54B | 184.04B | 498.19B | 522.51B | 525.92B | 477.74B | 435.69B | 379.98B |
| Gross Profit Ratio | 33.12% | 29.01% | 31.92% | 33.45% | 34.42% | 33.28% | 35.60% | 39.02% | 35.11% | 30.37% | 32.24% | 45.04% | 49.49% | 55.50% | 55.15% | 57.06% | 55.33% |
| Research & Development | 7.39B | 6.42B | 6.52B | 18.85B | 21.46B | 22.18B | 17.59B | 28.67B | 37.13B | 34.91B | 35.35B | 86.92B | 76.82B | 65.78B | 49.53B | 38.33B | 32.06B |
| General & Administrative | 57.35B | 41.50B | 39.37B | 35.64B | 32.78B | 17.68B | 20.58B | 24.33B | 17.62B | 16.53B | 15.84B | 70.22B | 76.91B | 71.95B | 82.75B | 91.63B | 80.16B |
| Selling & Marketing | 113.67B | 93.32B | 74.79B | 63.81B | 60.01B | 54.11B | 63.44B | 64.62B | 58.47B | 51.67B | 44.95B | 93.08B | 116.05B | 117.95B | 118.16B | 100.58B | 80.33B |
| SG&A | 171.01B | 134.82B | 114.17B | 99.45B | 92.79B | 71.79B | 84.01B | 88.95B | 76.09B | 68.19B | 60.78B | 163.30B | 192.96B | 189.90B | 200.91B | 192.21B | 160.48B |
| Other Expenses | 119.59B | 115.28B | 99.23B | 93.08B | 97.88B | 1.10B | 156.80M | 469.76M | 2.95B | 9.69B | 2.75B | 2.79B | 1.13B | 5.46B | -126.17M | -1.57B | -1.74B |
| Operating Expenses | 297.99B | 256.53B | 219.92B | 211.38B | 212.13B | 185.14B | 192.39B | 207.32B | 183.05B | 170.71B | 150.40B | 392.35B | 407.97B | 399.07B | 376.29B | 351.66B | 304.19B |
| Cost & Expenses | 1,055.12B | 977.01B | 820.38B | 732.71B | 716.86B | 656.95B | 636.89B | 650.17B | 640.38B | 609.80B | 537.23B | 1,000.15B | 941.16B | 820.78B | 764.79B | 679.56B | 611.02B |
| Interest Income | 4.38B | 2.45B | 1.19B | 1.90B | 1.98B | 2.18B | 2.42B | 1.57B | 2.26B | 3.84B | 5.46B | 8.11B | 4.89B | 6.13B | 3.78B | 3.56B | 4.00B |
| Interest Expense | 22.75B | 14.85B | 11.50B | 11.98B | 13.42B | 11.96B | 12.03B | 9.53B | 13.72B | 13.94B | 11.62B | 21.05B | 19.10B | 16.08B | 17.63B | 15.18B | 12.67B |
| Depreciation & Amortization | 74.17B | 70.73B | 59.37B | 53.28B | 45.57B | 24.15B | 23.13B | 27.39B | 26.31B | 21.56B | 22.00B | 37.80B | 33.91B | 32.59B | 28.19B | 22.77B | 18.59B |
| EBITDA | 141.37B | 88.10B | 120.94B | 243.54B | 101.97B | -125.30B | 76.50B | 103.39B | 90.67B | 42.58B | 55.44B | 172.84B | 154.77B | 162.72B | 132.36B | 109.02B | 97.78B |
| EBITDA Ratio | 12.49% | 10.80% | 15.07% | 30.06% | 12.64% | -18.07% | 11.95% | 29.83% | 18.86% | 10.02% | 12.16% | 15.73% | 15.09% | 17.60% | 15.71% | 12.14% | 14.24% |
| Operating Income | 76.88B | 37.85B | 61.56B | 182.14B | 52.82B | 50.55B | 53.37B | 76.00B | 64.36B | 20.83B | 33.64B | 105.84B | 113.51B | 126.86B | 101.44B | 84.03B | 75.78B |
| Operating Income Ratio | 6.79% | 3.73% | 6.98% | 23.25% | 6.86% | 7.15% | 7.73% | 10.47% | 9.13% | 3.30% | 5.89% | 9.57% | 10.75% | 13.39% | 11.71% | 11.00% | 11.03% |
| Total Other Income/Expenses | -11.15B | -20.25B | 4.54B | -11.96B | -14.14B | -223.67B | -6.24B | 121.77B | 29.72B | 4.47B | 546.47M | -63.79B | -10.32B | -12.82B | -14.91B | -12.96B | -18.42B |
| Income Before Tax | 65.73B | 17.61B | 66.10B | 170.18B | 38.68B | -173.12B | 47.14B | 197.77B | 94.08B | 25.29B | 34.19B | 113.99B | 103.20B | 114.04B | 86.54B | 71.07B | 57.36B |
| Income Before Tax Ratio | 5.81% | 1.74% | 7.50% | 21.73% | 5.03% | -24.48% | 6.83% | 27.23% | 13.35% | 4.01% | 5.99% | 10.31% | 9.78% | 12.03% | 9.99% | 9.31% | 8.35% |
| Income Tax Expense | 9.87B | 9.77B | 5.59B | 7.82B | 18.71B | -9.23B | 14.59B | 22.08B | 27.46B | 18.81B | 23.09B | 23.69B | 28.31B | 31.64B | 23.26B | 27.68B | 22.05B |
| Net Income | 57.99B | 7.84B | 60.27B | 162.35B | 19.76B | -163.98B | 32.54B | 149.05B | 47.88B | 1.72B | 15.57B | 85.88B | 69.22B | 71.48B | 63.26B | 43.38B | 34.76B |
| Net Income Ratio | 5.12% | 0.77% | 6.83% | 20.73% | 2.57% | -23.19% | 4.71% | 20.53% | 6.79% | 0.27% | 2.73% | 7.76% | 6.56% | 7.54% | 7.30% | 5.68% | 5.06% |
| EPS | 9.28K | 1.25K | 9.75K | 26.72K | 3.22K | -26.71K | 5.31K | 29.31K | 10.56K | 397.00 | 3.08K | 21.66K | 17.15K | 19.01K | 17.87K | 12.15K | 9.68K |
| EPS Diluted | 9.28K | 1.25K | 9.75K | 26.72K | 3.22K | -26.71K | 4.97K | 28.04K | 10.14K | 397.00 | 2.29K | 18.70K | 17.14K | 18.98K | 17.52K | 12.14K | 9.68K |
| Weighted Avg Shares Out | 6.25M | 6.25M | 6.18M | 6.07M | 6.14M | 6.14M | 6.13M | 5.09M | 4.53M | 4.32M | 5.05M | 3.96M | 4.04M | 3.76M | 3.54M | 3.57M | 3.59M |
| Weighted Avg Shares Out (Dil) | 6.25M | 6.25M | 6.18M | 6.07M | 6.14M | 6.14M | 6.55M | 5.32M | 4.72M | 4.32M | 6.79M | 4.59M | 4.04M | 3.77M | 3.61M | 3.57M | 3.59M |
Source: https://incomestatements.info
Category: Stock Reports